These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17301948)

  • 1. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
    Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
    Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
    J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
    Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
    J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
    Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
    J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mouse CD43 in the B cell lineage of transgenic mice causes impaired immune responses to T-independent antigens.
    Ostberg JR; Dragone LL; Borrello MA; Phipps RP; Barth RK; Frelinger JG
    Eur J Immunol; 1997 Sep; 27(9):2152-9. PubMed ID: 9341753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
    Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
    J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
    Marchbank KJ; Watson CC; Ritsema DF; Holers VM
    J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
    Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
    Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells.
    Brown SL; Barrault DV; Phythian-Adams A; Knight AM
    Int Immunol; 2006 Jan; 18(1):69-78. PubMed ID: 16291653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
    Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
    Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen.
    Plows D; Kontogeorgos G; Kollias G
    J Immunol; 1999 Jan; 162(2):1018-23. PubMed ID: 9916728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
    Fang Y; Xu C; Fu YX; Holers VM; Molina H
    J Immunol; 1998 Jun; 160(11):5273-9. PubMed ID: 9605124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
    J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2.
    Carlsson F; Getahun A; Rutemark C; Heyman B
    Scand J Immunol; 2009 Aug; 70(2):77-84. PubMed ID: 19630912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.
    Kraus M; Alimzhanov MB; Rajewsky N; Rajewsky K
    Cell; 2004 Jun; 117(6):787-800. PubMed ID: 15186779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The signaling activity of murine CD19 is regulated during cell development.
    Krop I; Shaffer AL; Fearon DT; Schlissel MS
    J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD83 is a regulator of murine B cell function in vivo.
    Breloer M; Kretschmer B; Lüthje K; Ehrlich S; Ritter U; Bickert T; Steeg C; Fillatreau S; Hoehlig K; Lampropoulou V; Fleischer B
    Eur J Immunol; 2007 Mar; 37(3):634-48. PubMed ID: 17266176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
    Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.